Shares of Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) were up 7.6% during trading on Tuesday. The company traded as high as $401.74 and last traded at $389.80. Approximately 6,489,137 shares traded hands during mid-day trading, an increase of 25% from the average daily volume of 5,191,556 shares. The stock had previously closed at $362.34.
Wall Street Analysts Forecast Growth
ALAB has been the topic of a number of research reports. Bank of America increased their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Susquehanna upped their price objective on Astera Labs from $230.00 to $275.00 and gave the stock a “neutral” rating in a research note on Friday, July 31st. Royal Bank Of Canada increased their target price on Astera Labs from $425.00 to $500.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Needham & Company LLC raised their target price on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Finally, Citigroup restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Twelve analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, Astera Labs presently has a consensus rating of “Moderate Buy” and an average price target of $348.33.
View Our Latest Stock Report on Astera Labs
Astera Labs Price Performance
Astera Labs (NASDAQ:ALAB – Get Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s revenue was up 104.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current fiscal year.
Insider Transactions at Astera Labs
In other Astera Labs news, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $340.50, for a total transaction of $2,315,740.50. Following the completion of the transaction, the general counsel directly owned 96,542 shares of the company’s stock, valued at approximately $32,872,551. This trade represents a 6.58% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of Astera Labs stock in a transaction on Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the transaction, the director owned 253,863 shares in the company, valued at approximately $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 396,059 shares of company stock valued at $122,605,660 over the last three months. 10.40% of the stock is owned by company insiders.
Institutional Trading of Astera Labs
A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs in the second quarter worth approximately $25,000. Archer Investment Corp bought a new stake in shares of Astera Labs during the 2nd quarter worth $30,000. Transamerica Financial Advisors LLC acquired a new position in shares of Astera Labs in the 2nd quarter worth $35,000. Continuum Advisory LLC acquired a new position in shares of Astera Labs in the 2nd quarter worth $37,000. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Astera Labs during the second quarter worth $43,000. 60.47% of the stock is currently owned by institutional investors.
Astera Labs Company Profile
Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.
The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.
Featured Stories
- Five stocks we like better than Astera Labs
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
